InnoTherapy Inc (246960) — Cash Flow-to-Debt Ratio
InnoTherapy Inc (246960) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of ₩-107.41 Million could theoretically repay 0% of its total liabilities (₩50.78 Billion) in one year. Explore InnoTherapy Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
InnoTherapy Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for InnoTherapy Inc across 10 annual periods. Also explore InnoTherapy Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for InnoTherapy Inc (2015–2024)
Year-by-year debt coverage analysis for InnoTherapy Inc. For market capitalisation and broader financial context, see 246960 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.70x | ₩-5.96 Billion | ₩8.54 Billion | ▼ -178.5% |
| 2023 | -0.25x | ₩-2.82 Billion | ₩11.26 Billion | ▼ -8.4% |
| 2022 | -0.23x | ₩-4.10 Billion | ₩17.77 Billion | ▼ -26.4% |
| 2021 | -0.18x | ₩-3.98 Billion | ₩21.80 Billion | ▲ +72.0% |
| 2020 | -0.65x | ₩-2.87 Billion | ₩4.41 Billion | ▲ +57.1% |
| 2019 | -1.52x | ₩-3.26 Billion | ₩2.15 Billion | ▼ -15.5% |
| 2018 | -1.31x | ₩-2.18 Billion | ₩1.66 Billion | ▲ +35.6% |
| 2017 | -2.04x | ₩-2.26 Billion | ₩1.11 Billion | ▼ -74.1% |
| 2016 | -1.17x | ₩-1.12 Billion | ₩957.90 Million | ▼ -1360.6% |
| 2015 | -0.08x | ₩-1.15 Billion | ₩14.34 Billion | — |